Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance.
Chemotherapy
Hodgkin lymphoma
classical
ferritin
prognostic factors
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
pubmed:
22
2
2022
medline:
21
4
2022
entrez:
21
2
2022
Statut:
ppublish
Résumé
Serum ferritin (SF) is frequently elevated in classical Hodgkin lymphoma (cHL). We report on its prognostic significance in an unselected series of 529 cHL patients treated with state-of-the-art therapy. Higher baseline levels correlated with markers of advanced/aggressive disease. SF levels were significantly higher in male and older patients, those with high body mass index and mixed cellularity histology. The strongest correlation was recorded between SF and complement reactive protein (CRP) levels. Gender-specific SF cutoffs which provided the best discrimination in terms of freedom from progression (FFP) were identified. In multivariate analysis elevated SF levels, advanced stage and high lactate dehydrogenase (LDH) were independent prognostic factors of inferior FFP. SF also appears to retain independent prognostic significance for progression-free survival (PFS) but not for overall survival (OS). In conclusion, SF levels in cHL reflect disease activity and are associated with adverse patient outcomes.
Identifiants
pubmed: 35188040
doi: 10.1080/10428194.2021.2010054
doi:
Substances chimiques
Biomarkers
0
Ferritins
9007-73-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
799-812Commentaires et corrections
Type : CommentIn